UY30444A1 - Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos. - Google Patents
Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.Info
- Publication number
- UY30444A1 UY30444A1 UY30444A UY30444A UY30444A1 UY 30444 A1 UY30444 A1 UY 30444A1 UY 30444 A UY30444 A UY 30444A UY 30444 A UY30444 A UY 30444A UY 30444 A1 UY30444 A1 UY 30444A1
- Authority
- UY
- Uruguay
- Prior art keywords
- pharmaccutic
- compositions
- processes
- preparation
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Se proporciona un compuesto de formula (I): proceso para la fabricacion del mismo, composiciones farmacéuticas del mismo y usos en terapias.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81825906P | 2006-06-30 | 2006-06-30 | |
US90842807P | 2007-03-28 | 2007-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30444A1 true UY30444A1 (es) | 2008-01-31 |
Family
ID=38472858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30444A UY30444A1 (es) | 2006-06-30 | 2007-06-27 | Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080004302A1 (es) |
EP (1) | EP2044063A1 (es) |
JP (1) | JP2009541480A (es) |
KR (1) | KR20090024270A (es) |
AR (1) | AR061737A1 (es) |
AU (1) | AU2007263655A1 (es) |
CA (1) | CA2654852A1 (es) |
IL (1) | IL195731A0 (es) |
MX (1) | MX2008016523A (es) |
NO (1) | NO20085217L (es) |
TW (1) | TW200817391A (es) |
UY (1) | UY30444A1 (es) |
WO (1) | WO2008001070A1 (es) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0104140D0 (sv) * | 2001-12-07 | 2001-12-07 | Astrazeneca Ab | Novel Compounds |
MX2007009437A (es) * | 2005-02-04 | 2007-08-16 | Astrazeneca Ab | Derivados de pirazolilaminopiridina utiles como inhibidores de cinasa. |
RU2405780C2 (ru) * | 2005-02-16 | 2010-12-10 | Астразенека Аб | Химические соединения |
BRPI0610184A2 (pt) * | 2005-05-16 | 2012-09-25 | Astrazeneca Ab | composto, sal farmaceuticamente aceitável de um composto, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, métodos para a inibição da atividade de trk, para o tratamento ou profilaxia de cáncer e para a produção de um efeito anti-proliferativo em um animal de sanque quente, e, composição farmacêutica |
DK1945631T3 (da) * | 2005-10-28 | 2012-10-22 | Astrazeneca Ab | 4- (3-aminopyrazole) pyrimidinderivater til anvendelse som tyrosinkinaseinhibitorer til behandling af cancer |
JP2010524911A (ja) * | 2007-04-18 | 2010-07-22 | アストラゼネカ アクチボラグ | 5−アミノピラゾール−3−イル−3H−イミダゾ[4,5−b]ピリジン誘導体と癌の治療のためのその使用 |
UA99459C2 (en) * | 2007-05-04 | 2012-08-27 | Астразенека Аб | 9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer |
EP2166849A4 (en) * | 2007-06-11 | 2010-09-15 | Miikana Therapeutics Inc | SUBSTITUTED PYRAZOL COMPOUNDS |
PE20091236A1 (es) | 2007-11-22 | 2009-09-16 | Astrazeneca Ab | Derivados de pirimidina como immunomoduladores de tlr7 |
RU2010154502A (ru) * | 2008-06-11 | 2012-07-20 | Астразенека Аб (Se) | Трициклические 2,4-диамино-l,3,5-триазиновые производные, пригодные для лечения злокачественного новообразования и миелопролиферативных нарушений |
WO2010005692A2 (en) * | 2008-06-16 | 2010-01-14 | E. I. Du Pont De Nemours And Company | Insecticidal cyclic carbonyl amidines |
KR20110071098A (ko) * | 2008-09-30 | 2011-06-28 | 아스트라제네카 아베 | 복소환 jak 키나제 억제제 |
CA2760766A1 (en) | 2009-05-21 | 2010-11-25 | Nicholas James Bennett | Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases |
GB0908772D0 (en) | 2009-05-21 | 2009-07-01 | Astrazeneca Ab | New salts 756 |
US8586581B2 (en) | 2009-12-17 | 2013-11-19 | Hoffmann-La Roche Inc | Ethynyl compounds useful for treatment of CNS disorders |
CN110269856A (zh) | 2010-03-30 | 2019-09-24 | 维颂公司 | 多取代芳族化合物作为凝血酶的抑制剂 |
CA2798578C (en) | 2010-05-21 | 2015-12-29 | Chemilia Ab | Novel pyrimidine derivatives |
WO2012050141A1 (ja) * | 2010-10-14 | 2012-04-19 | 住友化学株式会社 | ヘテロ芳香環化合物およびその有害生物防除用途 |
EP2651937B8 (en) | 2010-12-16 | 2016-07-13 | Sumitomo Dainippon Pharma Co., Ltd. | Imidazo[4,5-c]quinolin-1-yl derivative useful in therapy |
US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
RU2013147417A (ru) | 2011-03-24 | 2015-04-27 | Кемилиа Аб | Новые производные пиримидина |
EP2754659A4 (en) * | 2011-09-05 | 2015-08-26 | Zhejiang Hisun Pharm Co Ltd | 4-SUBSTITUTED- (3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO) -PYRIMIDINES DERIVATIVES HAVING PROTEIN KINASE INHIBITION ACTIVITY AND USE THEREOF |
ES2644702T3 (es) | 2012-05-18 | 2017-11-30 | Sumitomo Dainippon Pharma Co., Ltd. | Compuestos de ácido carboxílico |
LT3176170T (lt) | 2012-06-13 | 2019-04-25 | Incyte Holdings Corporation | Pakeisti tricikliniai junginiai, kaip fgfr inhibitoriai |
WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
JP6183053B2 (ja) * | 2012-08-22 | 2017-08-23 | 宇部興産株式会社 | テトラヒドロピラニルピリミジン化合物の製造方法 |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
DK2986610T5 (en) | 2013-04-19 | 2018-12-10 | Incyte Holdings Corp | BICYCLIC HETEROCYCLES AS FGFR INHIBITORS |
WO2016030534A1 (en) | 2014-08-29 | 2016-03-03 | Tes Pharma S.R.L. | INHIBITORS OF α-AMINO-β-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
CN107438607B (zh) | 2015-02-20 | 2021-02-05 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
AU2016224974B2 (en) * | 2015-02-27 | 2019-09-26 | Verseon Corporation | Substituted pyrazole compounds as serine protease inhibitors |
BR112018072168A2 (pt) | 2016-04-28 | 2019-02-12 | Theravance Biopharma R&D Ip, Llc | compostos derivados da pirimidina como inibidores da quinase jak |
WO2018132326A1 (en) | 2017-01-10 | 2018-07-19 | National Health Research Institutes | Heterocyclic compounds and use thereof |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
EA202091016A1 (ru) | 2017-10-27 | 2020-07-17 | ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи | Пиримидиновое соединение в качестве ингибитора jak киназы |
WO2019213506A1 (en) | 2018-05-04 | 2019-11-07 | Incyte Corporation | Salts of an fgfr inhibitor |
PE20210920A1 (es) | 2018-05-04 | 2021-05-19 | Incyte Corp | Formas solidas de un inhibidor de fgfr y procesos para prepararlas |
WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
TW202106681A (zh) | 2019-04-24 | 2021-02-16 | 美商施萬生物製藥研發Ip有限責任公司 | 用於治療皮膚疾病之嘧啶jak抑制劑 |
US11155549B2 (en) | 2019-04-24 | 2021-10-26 | Theravance Biopharma R&D Ip, Llc | Ester and carbonate pyrimidine compounds as JAK kinase inhibitors |
CN110143939A (zh) * | 2019-05-07 | 2019-08-20 | 中国科学技术大学 | 一种由呋喃醛基化合物制备呋喃丙烯酸酯的方法 |
WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
KR20220100879A (ko) | 2019-10-14 | 2022-07-18 | 인사이트 코포레이션 | Fgfr 저해제로서의 이환식 헤테로사이클 |
WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
PE20221504A1 (es) | 2019-12-04 | 2022-09-30 | Incyte Corp | Derivados de un inhibidor de fgfr |
JP2023505258A (ja) | 2019-12-04 | 2023-02-08 | インサイト・コーポレイション | Fgfr阻害剤としての三環式複素環 |
US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
TW202402288A (zh) | 2022-05-26 | 2024-01-16 | 義大利商Tes製藥(股份)責任有限公司 | 用於治療急性炎症之嘧啶酮化合物 |
CN115466234B (zh) * | 2022-10-25 | 2024-01-30 | 安徽华业香料股份有限公司 | 一种γ-庚内酯的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6613776B2 (en) * | 2000-09-15 | 2003-09-02 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
US6610677B2 (en) * | 2000-09-15 | 2003-08-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
EP1317450B1 (en) * | 2000-09-15 | 2006-11-22 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
US7473691B2 (en) * | 2000-09-15 | 2009-01-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
US6660731B2 (en) * | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
NZ526471A (en) * | 2000-12-21 | 2005-08-26 | Vertex Pharma | Pyrazole compounds useful as protein kinase inhibitors |
SE0104140D0 (sv) * | 2001-12-07 | 2001-12-07 | Astrazeneca Ab | Novel Compounds |
DE602004022187D1 (de) * | 2003-10-17 | 2009-09-03 | Astrazeneca Ab | 4-(pyrazol-3-ylamino)pyrimidinderivate zur verwendung bei der behandlung von krebs |
MY141220A (en) * | 2003-11-17 | 2010-03-31 | Astrazeneca Ab | Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
ATE519759T1 (de) * | 2004-12-30 | 2011-08-15 | Exelixis Inc | Pyrimidinderivate als kinasemodulatoren und anwendungsverfahren |
-
2007
- 2007-06-27 JP JP2009517388A patent/JP2009541480A/ja active Pending
- 2007-06-27 UY UY30444A patent/UY30444A1/es unknown
- 2007-06-27 AU AU2007263655A patent/AU2007263655A1/en not_active Abandoned
- 2007-06-27 CA CA002654852A patent/CA2654852A1/en not_active Abandoned
- 2007-06-27 MX MX2008016523A patent/MX2008016523A/es not_active Application Discontinuation
- 2007-06-27 KR KR1020097001201A patent/KR20090024270A/ko not_active Application Discontinuation
- 2007-06-27 WO PCT/GB2007/002381 patent/WO2008001070A1/en active Application Filing
- 2007-06-27 EP EP07733374A patent/EP2044063A1/en not_active Withdrawn
- 2007-06-27 TW TW096123274A patent/TW200817391A/zh unknown
- 2007-06-27 US US11/769,417 patent/US20080004302A1/en not_active Abandoned
- 2007-06-29 AR ARP070102909A patent/AR061737A1/es unknown
-
2008
- 2008-12-04 IL IL195731A patent/IL195731A0/en unknown
- 2008-12-15 NO NO20085217A patent/NO20085217L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2009541480A (ja) | 2009-11-26 |
TW200817391A (en) | 2008-04-16 |
US20080004302A1 (en) | 2008-01-03 |
AR061737A1 (es) | 2008-09-17 |
KR20090024270A (ko) | 2009-03-06 |
MX2008016523A (es) | 2009-01-19 |
CA2654852A1 (en) | 2008-01-03 |
EP2044063A1 (en) | 2009-04-08 |
AU2007263655A1 (en) | 2008-01-03 |
IL195731A0 (en) | 2009-09-01 |
WO2008001070A1 (en) | 2008-01-03 |
NO20085217L (no) | 2009-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30444A1 (es) | Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos. | |
UY30472A1 (es) | Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones. | |
ECSP077271A (es) | Derivados de pirimidina | |
ECSP077259A (es) | Derivados de pirimidina | |
UY30912A1 (es) | Derivados de 4-pirazol amidas conteniendo carboxi, sales farmacéuticamente aceptables de los mismo, composiciones farmacéuticas conteniéndolos, procesos de preparacion y uso. | |
BR122019010008B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
CO6290656A2 (es) | Derivados heterociclicos de urea y metodos de uso de los mismos -211 | |
UY31918A (es) | Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento | |
CO6541643A2 (es) | Derivados de imidazopirina como inhibidores de jak | |
CL2011002115A1 (es) | Compuestos derivados de 5-fenil-1h-piridin-2-ona y 5-fenil-pirazin-2-ona, inhibidores de la tirosina-quinasa de bruton (btk); proceso de preparación de los compuestos, compuesto intermediario, composición farmacéutica y uso en el tratamiento de enfermedades inflamatorias y/o autoinmunes. | |
UY31183A1 (es) | Derivados de pirazinona y procesos para su preparación | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
CR20120427A (es) | Derivados de pirazol como inhibidores de jak | |
UY30819A1 (es) | Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
ECSP088975A (es) | Nuevos análagos de piridina | |
EA201001205A1 (ru) | Соединения, содержащие циклобутоксигруппу | |
BR112013023876A2 (pt) | derivados de pirroltriazinona como inibidores de pi3k | |
UY30976A1 (es) | Nuevos derivados de quinolina, composiciones farmaccuticas que los contienen, procesos de preparacion y aplicaciones. | |
UY29325A1 (es) | Nuevos derivados de 2 - amino-piridina | |
UY29826A1 (es) | Derivados de pirimidina, sales farmaceuticamente aceptables, esteres de los mismos hidrolisables in vivo, procesos de preparacion y aplicaciones | |
BR112015007231A2 (pt) | derivados de pirroltriazinona como inibidores de pi3k | |
MX2012002876A (es) | Derivados de dihidropteridinona, proceso para su preparacion y uso farmaceutico. | |
UY29648A1 (es) | Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
UY29896A1 (es) | Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
UY29003A1 (es) | Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DESI | Application deemed to be withdrawn |
Effective date: 20120606 |